Erschienen in:
Open Access
01.04.2013 | Poster presentation
A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients
verfasst von:
D Schädler, C Porzelius, A Jörres, G Marx, A Meier-Hellmann, C Putensen, M Quintel, C Spies, C Engel, N Weiler, M Kuhlmann
Erschienen in:
Critical Care
|
Sonderheft 2/2013
Einloggen, um Zugang zu erhalten
Excerpt
A novel sorbent hemoadsorption device for cytokine removal (CytoSorbents, USA) was developed and successfully tested in animal models of sepsis. The experience in the clinical setting is still limited to case reports. In this first clinical trial, we tested the hypothesis that treatment with sorbent hemoadsorption could safely and effectively reduce cytokines in septic patients with acute lung injury (ALI). …